Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Loss of ZFP36 expression in colorectal cancer correlates to wnt/ ß-catenin activity and enhances epithelial-to-mesenchymal transition through upregulation of ZEB1, SOX9 and MACC1.
Montorsi L, Guizzetti F, Alecci C, Caporali A, Martello A, Atene CG, Parenti S, Pizzini S, Zanovello P, Bortoluzzi S, Ferrari S, Grande A, Zanocco-Marani T. Montorsi L, et al. Among authors: pizzini s. Oncotarget. 2016 Sep 13;7(37):59144-59157. doi: 10.18632/oncotarget.10828. Oncotarget. 2016. PMID: 27463018 Free PMC article.
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression.
Perilli L, Vicentini C, Agostini M, Pizzini S, Pizzi M, D'Angelo E, Bortoluzzi S, Mandruzzato S, Mammano E, Rugge M, Nitti D, Scarpa A, Fassan M, Zanovello P. Perilli L, et al. Among authors: pizzini s. Oncotarget. 2014 Aug 30;5(16):6611-9. doi: 10.18632/oncotarget.2245. Oncotarget. 2014. PMID: 25115394 Free PMC article.
An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer.
Agostini M, Janssen KP, Kim IJ, D'Angelo E, Pizzini S, Zangrando A, Zanon C, Pastrello C, Maretto I, Digito M, Bedin C, Jurisica I, Rizzolio F, Giordano A, Bortoluzzi S, Nitti D, Pucciarelli S. Agostini M, et al. Among authors: pizzini s. Oncotarget. 2015 Oct 20;6(32):32561-74. doi: 10.18632/oncotarget.4935. Oncotarget. 2015. PMID: 26359356 Free PMC article.
Human miRNome profiling in colorectal cancer and liver metastasis development.
Perilli L, Pizzini S, Bisognin A, Mandruzzato S, Biasiolo M, Facciolli A, Rossi E, Esposito G, Rugge M, Pilati P, Mocellin S, Nitti D, Bortoluzzi S, Zanovello P. Perilli L, et al. Among authors: pizzini s. Genom Data. 2014 Jun 27;2:184-8. doi: 10.1016/j.gdata.2014.06.017. eCollection 2014 Dec. Genom Data. 2014. PMID: 26484092 Free PMC article.
A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells.
Calura E, Pizzini S, Bisognin A, Coppe A, Sales G, Gaffo E, Fanelli T, Mannarelli C, Zini R, Norfo R, Pennucci V, Manfredini R, Romualdi C, Guglielmelli P, Vannucchi AM, Bortoluzzi S. Calura E, et al. Among authors: pizzini s. Blood Cancer J. 2016 Jun 24;6(6):e439. doi: 10.1038/bcj.2016.47. Blood Cancer J. 2016. PMID: 27341078 Free PMC article.
A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy.
Sidarovich V, De Mariano M, Aveic S, Pancher M, Adami V, Gatto P, Pizzini S, Pasini L, Croce M, Parodi F, Cimmino F, Avitabile M, Emionite L, Cilli M, Ferrini S, Pagano A, Capasso M, Quattrone A, Tonini GP, Longo L. Sidarovich V, et al. Among authors: pizzini s. Mol Cancer Ther. 2018 Jul;17(7):1405-1415. doi: 10.1158/1535-7163.MCT-17-0841. Epub 2018 Apr 25. Mol Cancer Ther. 2018. PMID: 29695637
72 results